Bal Pharma dispatches antiviral drug Favipiravir at Rs 85/tablet Kumar Jeetendra | May 24, 2021 Drug maker Bal Pharma on Monday said it has launched antiviral drug Favipiravir in the domestic market under the brand name BALflu for the treatment of COVID-19. The Bengaluru-based company said its formulation would be available in tablet form with 400 mg strength. Favipiravir is being used for patients with mild to moderate COVID-19 infection as it …
Roche’s Antibody Cocktail (Casirivimab and Imdevimab) is now available in India, Cipla to market it pan-India Kumar Jeetendra | May 24, 2021 Mumbai, 24 May 2021: Roche India and Cipla Limited (BSE: 500087; NSE: CIPLA EQ, referred to as “Cipla”) today announced that the first batch of the Antibody Cocktail (Casirivimab and Imdevimab) is now available in India while a second batch will be made available by mid-June. In total they can potentially benefit 200,000 patients as …
Sun Pharma reviews 50,868 bottles of diabetes drug in US Kumar Jeetendra | May 22, 2021 New Delhi, May 21 (PTI) Drug major Sun Pharma is recalling 50,868 bottles of diabetes drug Metformin HCl extended-release tablets in the US market, according to the US Food and Drug Administration (USFDA). The US-based arm of the drug firm is recalling the affected lot of 500 mg tablets (in 500 count bottles) due to …
Natco Pharma gets USFDA gesture for generic cancer trearment drug Kumar Jeetendra | May 22, 2021 New Delhi, May 22 (PTI) Natco Pharma on Saturday said it has received approval from the US health regulator for generic Lenalidomide capsules indicated for treatment of adults with multiple myeloma, mantle cell lymphoma and myelodysplastic syndromes. The company has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new …
Cipla launches ‘ViraGen’ a polymerase chain reaction (Covid-19 RT-PCR) test Kumar Jeetendra | May 20, 2021 Mumbai, India; May 20 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ, referred to as “Cipla”) today announced the commercialisation of a polymerase chain reaction (RT-PCR) test kit ‘ViraGen’ for COVID-19 in India, in partnership with Ubio Biotechnology Systems Pvt. Ltd. ViraGen is Cipla’s third offering in the Covid-19 testing segment. Cipla already has partnerships …
Optimus Pharma gets DCGI gesture to lead Phase-3 preliminary of COVID-19 antiviral drug Kumar Jeetendra | May 19, 2021 The orally administered drug is being tested for treating mild and moderate infection Optimus Pharma has obtained the approval of the Drug Controller General of India (DCGI) to conduct Phase III clinical trials of orally administered Molnupiravir capsules on patients with mild and moderate Covid-19 infection. In accordance with the clinical trial protocols approved, a …
Singapore endorses Pfizer-BioNTech COVID-19 antibody for use in 12 to 15-year-olds Kumar Jeetendra | May 18, 2021 Singapore has authorised the use of the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15 years old in a bid to extend protection to more groups as the country tackles a recent increase of infections, officials said on Tuesday.“The data showed that the Pfizer-BioNTech COVID-19 vaccine demonstrated high efficacy consistent with that observed in …
Too soon to say second wave has topped; immunization accessibility national bottleneck: CRISIL Kumar Jeetendra | May 17, 2021 Even as new COVID-19 infections have shown a declining trend, credit rating agency Crisil on Monday said it is “too early” to say that the second wave of the pandemic has peaked and flagged concerns over the vaccination drive. After opening up the vaccination for all adults, the drive has suffered because availability of vaccines …
What is the Moderna COVID immunization? Does it work, and is it safe? Kumar Jeetendra | May 16, 2021 Overnight, Boston-based pharmaceutical company Moderna announced a new supply agreement with Australia for 25 million doses of its COVID-19 vaccine. The deal includes ten million doses against the original strain of the coronavirus to be delivered this year. This vaccine has been widely used in countries such as Canada, United States and the United Kingdom …
Alembic Pharma gets USFDA gesture for bipolar depression drug Kumar Jeetendra | May 15, 2021 New Delhi, May 14 (PTI) Drug firm Alembic Pharmaceuticals on Friday said it has received final approval from the US health regulator for Lurasidone Hydrochloride tablets, used to treat bipolar depression. The approved product is therapeutically equivalent to the reference listed drug product (RLD) Latuda tablets of Sunovion Pharmaceuticals Inc. The company has received approval …
Gland Pharma gets USFDA gesture for generic Foscarnet Sodium injection Kumar Jeetendra | May 15, 2021 New Delhi, Apr 22 (PTI) Drug firm Gland Pharma on Thursday said it has received approval from the US health regulator for its generic Foscarnet Sodium injection indicated for treatment of cytomegalovirus retinitis in patients with AIDS. The company has received “approval from the United States Food and Drug Administration (USFDA) for its Foscarnet Sodium …
Cipla Enters into a Licensing Agreement with Lilly to Expand Access to COVID-19 Treatment in India Kumar Jeetendra | May 10, 2021 Mumbai, India, May 10, 2021: Cipla Limited (BSE: 500087 | NSE: CIPLA EQ, hereafter referred to as “Cipla”) today announced it has signed a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company, USA for the manufacture and commercialization of the drug baricitinib for Covid-19 indication. Baricitinib was issued a restricted emergency use approval …
